Literature DB >> 9385086

Generalizations of current status data with applications.

N P Jewell1, M V Laan.   

Abstract

In estimation of a survival function, current status data arises when the only information available on individuals is their survival status at a single monitoring time. Here, we briefly review extensions of this form of data structure in two directions: (i) doubly censored current status data, where there is incomplete information on the origin of the failure time random variable, and (ii) current status information on more complicated stochastic processes. Simple examples of these data forms are presented for motivation.

Mesh:

Year:  1995        PMID: 9385086     DOI: 10.1007/bf00985261

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  5 in total

1.  Statistical analysis of HIV infectivity based on partner studies.

Authors:  N P Jewell; S C Shiboski
Journal:  Biometrics       Date:  1990-12       Impact factor: 2.571

2.  Analysis of doubly-censored survival data, with application to AIDS.

Authors:  V De Gruttola; S W Lagakos
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

3.  Proportional hazards models for current status data: application to the study of differentials in age at weaning in Pakistan.

Authors:  I D Diamond; J W McDonald; I H Shah
Journal:  Demography       Date:  1986-11

4.  Nonparametric estimation of lifetime and disease onset distributions from incomplete observations.

Authors:  G E Dinse; S W Lagakos
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

5.  Estimating patterns of CD4 lymphocyte decline using data from a prevalent cohort of HIV infected individuals.

Authors:  E Vittinghoff; H M Malani; N P Jewell
Journal:  Stat Med       Date:  1994-06-15       Impact factor: 2.373

  5 in total
  9 in total

1.  Saddlepoint p-values and confidence intervals for a class of two sample permutation tests for current status and panel count data.

Authors:  Ehab F Abd-Elfattah
Journal:  Lifetime Data Anal       Date:  2010-12-08       Impact factor: 1.588

2.  Nonparametric estimation of the mean function of a stochastic process with missing observations.

Authors:  X Joan Hu; Stephen W Lagakos
Journal:  Lifetime Data Anal       Date:  2007-03       Impact factor: 1.588

3.  CURRENT STATUS AND RIGHT-CENSORED DATA STRUCTURES WHEN OBSERVING A MARKER AT THE CENSORING TIME.

Authors:  Mark J VAN DER Laan; Nicholas P Jewell
Journal:  Ann Stat       Date:  2003       Impact factor: 4.028

4.  Estimation from current-status data in continuous time.

Authors:  N Keiding; K Begtrup; T H Scheike; G Hasibeder
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

5.  Regression analysis of current status data in the presence of a cured subgroup and dependent censoring.

Authors:  Yeqian Liu; Tao Hu; Jianguo Sun
Journal:  Lifetime Data Anal       Date:  2016-09-30       Impact factor: 1.588

6.  Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.

Authors:  Theodore E Warkentin; Richard J Cook; Victor J Marder; Jo-Ann I Sheppard; Jane C Moore; Bengt I Eriksson; Andreas Greinacher; John G Kelton
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

Review 7.  Interval censoring.

Authors:  Zhigang Zhang; Jianguo Sun
Journal:  Stat Methods Med Res       Date:  2009-08-04       Impact factor: 3.021

8.  Enteropathogen antibody dynamics and force of infection among children in low-resource settings.

Authors:  Benjamin F Arnold; Diana L Martin; Jane Juma; Harran Mkocha; John B Ochieng; Gretchen M Cooley; Richard Omore; E Brook Goodhew; Jamae F Morris; Veronica Costantini; Jan Vinjé; Patrick J Lammie; Jeffrey W Priest
Journal:  Elife       Date:  2019-08-19       Impact factor: 8.140

9.  Factors Associated With HIV Infection in Zimbabwe Over a Decade From 2005 to 2015: An Interval-Censoring Survival Analysis Approach.

Authors:  Rutendo Birri Makota; Eustasius Musenge
Journal:  Front Public Health       Date:  2019-09-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.